A Critical Study on Acylating and Covalent Reversible Fragment Inhibitors of SARS-CoV-2 Main Protease Targeting the S1 Site with Pyridine.
ChemMedChem
; 18(9): e202200635, 2023 05 02.
Article
in En
| MEDLINE
| ID: mdl-36812048
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Journal:
ChemMedChem
Journal subject:
FARMACOLOGIA
/
QUIMICA
Year:
2023
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Alemania